[1. Fernandez-Berges D, Bertomeu-Gonzalez V, Sanchez PL, Cruz-Fernandez JM, Arroyo R, Barriales Alvarez V, Carrasco Sanchez FJ, Dalli E, Castro Beiras A, Kaski JC. (2011). Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome. Int J Cardiol. 146: 219-224.]Search in Google Scholar
[2. De Aralijo Goncalves P, Fereira J, Aguiar C, Seabra-Gomes R. (2005). TIMI, PURSUIT and GRACE risk scores: sustained prognostic value and interaction with revascularisation in NSTE-ACS. Eur Heart J. 26: 865-872.]Search in Google Scholar
[3. Aragam KG, Tamhane UU, Kline-Rogers E, Li J, Fox KA, Goodman SG, Eagle KA, Gurm HS. (2009). Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. PLoS One. 4: e7947.]Search in Google Scholar
[4. Ang DS, Wei L, Kao MP, Lang CC, Struthers AD. (2009). A comparison between B-type natriuretic peptide, global registry of acute coronary events (GRACE) score and their combination in ACS risk stratification. Heart. 95: 1836-1842.]Search in Google Scholar
[5. Pencina MJ, D’Agostino RB Sr, Steyerberg EW. (2011). Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 30: 11-21.]Search in Google Scholar
[6. Schiele F, Meneveau N, Seronde MF, Chopard R, Descotes-Genon V, Dutheil J, Bassand JP. (2010). C-reactive protein improves risk prediction in patients with acute coronary syndromes. Eur Heart J. 31: 290-297.]Search in Google Scholar
[7. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. (2009). Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 54: 357-364.]Search in Google Scholar
[8. Carruthers KF, Dagbous OH, Flather MD, Starkey I, Jacob A, MacLeod D et al. (2005). behalf of the GRACE investigators. Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE). Heart. 91: 290-298.]Search in Google Scholar
[9. Yan AT, Yan RT, Huynh T, Casanova A, Raimondo FE, Fitchett DH, Langer A, Goodman SG. (2009). Understanding physicians’ risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry. Arch Intern Med. 169: 372-378.]Search in Google Scholar
[10. Gale CP, Manda SO,Weston CF, Birkhead JS, Batin PD, Hall AS. (2009). Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database. Heart. 95: 221-227.]Search in Google Scholar
[11. Morrow DA (2010). Cardiovascular risk prediction in patients with stable and unstable coronary heart disease. Circulation. 121: 2681-2691.]Search in Google Scholar
[12. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S. (2009). Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 360: 2165-2175.]Search in Google Scholar
[13. Morrow DA, Antman EM, Fox KA, Knite HD, Giuliano R, Myrphy SA, McCabeand CH, Braunwald E. (2010). One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year result of the EXTRACT-TIMI 25 trial. Eur Heart J. 31: 2097-2102.]Search in Google Scholar
[14. McCullough PA, Gi bson CM, DiBattiste PM, et al. (2004). For the TACTIS TIMI-18 Investigators: Timing of angiography and revascularisation in acute coronary syndromes: An analysis from the TACTIS TIMI-18 trial. J Interv Cardiol. 17: 81.]Search in Google Scholar
[15. Diderholm E, Andren B, Frostfeldt G et al. (2002). The prognosticand therapeutic implications of increased troponin levels and ST depresion in unstable coronary artery disease: the FRASC II invasive troponin T electrocardiogram sybstudy. Am Heart J. 143: 760-767.]Search in Google Scholar
